Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest of Medicale Corp. from 30 Sep 2020 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
Medicale Corp. quarterly and annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD history and change rate from 30 Sep 2020 to 30 Sep 2024.
  • Medicale Corp. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending 30 Sep 2024 was $16,881, a 19% decline year-over-year.
  • Medicale Corp. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending 30 Sep 2024 was $58,213, a 55% decline year-over-year.
  • Medicale Corp. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2024 was $58,213, a 55% decline from 2023.
  • Medicale Corp. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was $37,593, a 15% increase from 2022.
  • Medicale Corp. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was $44,019, a 37% decline from 2021.
Source SEC data
View on sec.gov
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Change (%)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Change (%)

Medicale Corp. Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $58,213 $16,881 -$2,654 -19% 01 Jul 2024 30 Sep 2024 10-K 14 Jan 2025 2024 FY
Q2 2024 $55,559 $10,461 -$1,924 -23% 01 Apr 2024 30 Jun 2024 10-Q 15 Aug 2024 2024 Q3
Q1 2024 $53,635 $11,564 -$5,449 -89% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q2
Q4 2023 $48,186 $19,307 -$10,593 -122% 01 Oct 2023 31 Dec 2023 10-Q 15 Feb 2024 2024 Q1
Q3 2023 $37,593 $14,227 -$473 -3.4% 01 Jul 2023 30 Sep 2023 10-K 14 Jan 2025 2024 FY
Q2 2023 $37,120 $8,537 -$2,403 -39% 01 Apr 2023 30 Jun 2023 10-Q 15 Aug 2024 2024 Q3
Q1 2023 $34,717 $6,115 -$80 -1.3% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q2
Q4 2022 $34,637 $8,714 +$9,382 +52% 01 Oct 2022 31 Dec 2022 10-Q 15 Feb 2024 2024 Q1
Q3 2022 $44,019 $13,754 01 Jul 2022 30 Sep 2022 10-K 02 Jan 2024 2023 FY
Q2 2022 $6,134 01 Apr 2022 30 Jun 2022 10-Q/A 21 Aug 2023 2023 Q3
Q1 2022 $6,035 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023 2023 Q2
Q4 2021 $18,096 -$6,582 -57% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q1
Q4 2020 $11,514 01 Oct 2020 31 Dec 2020 10-Q 01 Feb 2021 2021 Q1
Q3 2020 $1,923 17 Aug 2020 30 Sep 2020 10-K 15 Dec 2021 2021 FY

Medicale Corp. Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $58,213 -$20,620 -55% 01 Oct 2023 30 Sep 2024 10-K 14 Jan 2025 2024 FY
2023 $37,593 +$6,426 +15% 01 Oct 2022 30 Sep 2023 10-K 14 Jan 2025 2024 FY
2022 $44,019 -$11,867 -37% 01 Oct 2021 30 Sep 2022 10-K 02 Jan 2024 2023 FY
2021 $32,152 01 Oct 2020 30 Sep 2021 10-K 02 Dec 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.